Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model....

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: t
View:

• 18 years of age or older.

• Adequate venous access.

• Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer.

• Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000

• Be willing and able to provide written informed consent on screening, comply with study requirements and procedures, and comply with clinic policies

• Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, and undergo hepatitis screening

Locations
United States
Washington, D.c.
Washington Hospital Center
COMPLETED
Washington D.c.
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Catherine A Seamon, R.N.
cseamon@cc.nih.gov
(301) 402-3481
Backup
Susan L Moir, Ph.D.
sm221a@nih.gov
(301) 402-4559
Time Frame
Start Date: 1993-03-09
Participants
Target number of participants: 2400
Treatments
Individuals living with/without HIV
Individuals living with/without HIV
Individuals living with/without infectious diseases
Individuals living with/without infectious diseases of interest
Individuals with/without Immunodeficiencies
Individuals with/without immunodeficiencies
Authors
Susan Moir
Related Therapeutic Areas
Sponsors
Leads: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Medstar Health Research Institute

This content was sourced from clinicaltrials.gov